PC involves genetic alterations that frequently occur in genes, namely KRAS [4],CDKN2A [5], TP53 [6–8] and SMAD4/DPC4 [9], causing aberrant effector signaling by the expression of constitutively activated or inactivated mutants. This evidence concerns the gene KRAS and pachyonychia congenita.